These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7988642)

  • 1. Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat.
    Ahlenius S; Salmi P
    Eur J Pharmacol; 1994 Aug; 260(2-3):177-81. PubMed ID: 7988642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat.
    Ahlenius S; Hillegaart V; Wijkström A
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):551-6. PubMed ID: 2570361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors.
    Starr MS; Starr BS
    Eur J Pharmacol; 1995 Apr; 277(2-3):151-8. PubMed ID: 7493603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed agonist-antagonist properties of umespirone at neostriatal dopamine receptors in relation to its behavioral effects in the rat.
    Ahlenius S; Wijkström A
    Eur J Pharmacol; 1992 Nov; 222(1):69-74. PubMed ID: 1361441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011.
    Gyertyán I; Sághy K
    Behav Pharmacol; 2004 Jul; 15(4):253-62. PubMed ID: 15252275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors.
    Svensson K; Carlsson A; Huff RM; Kling-Petersen T; Waters N
    Eur J Pharmacol; 1994 Oct; 263(3):235-43. PubMed ID: 7843260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of (+/-)-7-hydroxy-N,N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in limbic and extrapyramidal regions of rat brain.
    Booth RG; Baldessarini RJ; Marsh E; Owens CE
    Brain Res; 1994 Oct; 662(1-2):283-8. PubMed ID: 7859086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D2 and D1 dopaminergic activity of 7-OH-DPAT.
    Sethy VH; Ellerbrock BR; Fici GJ; Wu H
    Brain Res; 1996 Sep; 733(1):41-5. PubMed ID: 8891246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiophene analogs of naphthoxazines and 2-aminotetralins: bioisosteres with improved relative oral bioavailability, as compared to 5-OH-DPAT.
    Rodenhuis N; Timmerman W; Wikström HV; Dijkstra D
    Eur J Pharmacol; 2000 Apr; 394(2-3):255-63. PubMed ID: 10771291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine.
    Depoortere R; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1996 Apr; 124(3):231-40. PubMed ID: 8740044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis.
    Gainetdinov RR; Sotnikova TD; Grekhova TV; Rayevsky KS
    Eur J Pharmacol; 1996 Jul; 308(3):261-9. PubMed ID: 8858296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 5-HT1A receptor agonists on patterns of rat motor activity in relation to effects on forebrain monoamine synthesis.
    Ahlenius S; Hillegaart V; Salmi P; Wijkström A
    Pharmacol Toxicol; 1993 Jun; 72(6):398-406. PubMed ID: 8361951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 7-hydroxy-N,N-di-n-propylaminotetralin on behaviour and blood pressure of spontaneously hypertensive rats.
    Van den Buuse M
    Eur J Pharmacol; 1993 Oct; 243(2):169-77. PubMed ID: 8276066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S 14297, a novel selective ligand at cloned human dopamine D3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats.
    Millan MJ; Audinot V; Rivet JM; Gobert A; Vian J; Prost JF; Spedding M; Peglion JL
    Eur J Pharmacol; 1994 Aug; 260(2-3):R3-5. PubMed ID: 7988633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive hypothermic effects of the 5-HT1A receptor agonist 8-OH-DPAT and the dopamine D2/3 receptor agonist 7-OH-DPAT in the rat.
    Eltayb A; Lindblom S; Oerther S; Ahlenius S
    Acta Physiol Scand; 2001 Jul; 172(3):205-9. PubMed ID: 11472307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
    Rogóz Z; Skuza G
    Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
    Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand.
    Damsma G; Bottema T; Westerink BH; Tepper PG; Dijkstra D; Pugsley TA; MacKenzie RG; Heffner TG; Wikström H
    Eur J Pharmacol; 1993 Nov; 249(3):R9-10. PubMed ID: 8287911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional topography of brain serotonergic pathways in the rat.
    Hillegaart V
    Acta Physiol Scand Suppl; 1991; 598():1-54. PubMed ID: 1832809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the dopamine D3 receptor ligand 7-OH-DPAT on male rat ejaculatory behavior.
    Ahlenius S; Larsson K
    Pharmacol Biochem Behav; 1995; 51(2-3):545-7. PubMed ID: 7667384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.